Gossamer Bio
GOSS
GOSS
115 hedge funds and large institutions have $430M invested in Gossamer Bio in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 35 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
32% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 25
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
86% less call options, than puts
Call options by funds: $424K | Put options by funds: $3.11M
Holders
115
Holding in Top 10
1
Calls
$424K
Puts
$3.11M
Top Buyers
| 1 | +$9.54M | |
| 2 | +$6.7M | |
| 3 | +$6.6M | |
| 4 |
Millennium Management
New York
|
+$4.6M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.66M |
Top Sellers
| 1 | -$5.81M | |
| 2 | -$5.28M | |
| 3 | -$4.58M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.37M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.06M |